PARABO - Pain evaluation in Radium-223 (Xofigo®) treated mCRPC patients with bone metastases – a non-interventional study in nuclear medicine centers | HMA-EMA Catalogues of real-world data sources and studies

Study protocol

Initial protocol

XF1412_CSP_v1.0_2014-09-12_signed_reduced

English (766.62 KB - PDF) View document

Updated protocol

17550_PARABO_CSP_v6.0_2018-04-30_redacted

First published: 22/02/2024

English (2.37 MB - PDF) View document

Study results

17750_EU PAS Abstract_2021-07-07

English (332.87 KB - PDF) View document

Study report

17550_Clinical Study Report_V1.0_20210601_redacted

English (9.86 MB - PDF) View document

17550_Clinical Study Report_V2.0_2021-06-28_redacted

English (1.46 MB - PDF) View document

Other information

Study, other information

17550_Clinical Study Report_V2.0_2021-06-28_redacted.pdf

English (1.46 MB - PDF) View document

PARABO - Pain evaluation in Radium-223 (Xofigo®) treated mCRPC patients with bone metastases – a non-interventional study in nuclear medicine centers